Tidepool

Plug’n play API to integrate with your diabetes management platform. Personalized therapeutic education. Better insights on BGL fluctuations. Real-time prediction to anticipate risks. Allow for more personalization and better regulation of the system. Handle complex living phases with rapid glucose changes. Telemedicine & retrospective analysis. Decision-support for patients. Hillo is currently working on the next versions of its AI technology, a therapeutic recommendation system to anticipate and prevent hypoglycemia and hyperglycemia, whose CE mark class IIB is planned for 2020, and the new generation of artificial pancreas(AP) for 2021, which will help overcome the main limitations of current AP systems thanks to the ultra-personalization provided by machine learning. The first self-learning artificial intelligence for predicting blood glucose levels to obtain CE mark as a medical device.

Whether seeking treatment for a common cold or a chronic condition like diabetes or heart disease, when people are sick or have a family member facing illness, they often have questions, concerns, or could use guidance to ensure they understand and are able to adhere to their treatment. Health Dialog offers a suite of personalized population health solutions that address these issues and empower your members to improve their whole-being health, while reducing overall costs. Our healthcare experts provide one-on-one health coaching through personalized outreach to help identified members better manage their chronic conditions, such as asthma, diabetes and heart disease. We identify members at-risk for nonadherence, determine the best method for engaging them, and educate them to encourage ongoing medication-taking behavior. Give your members 24/7 access to a live registered nurse who can provide clinical advice, refer services, impart skills and provide relevant educational materials.